Aster DM Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider and approve Quarterly Results and Other Matters
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aster DM Healthcare has informed exchanges that its Board of Directors will meet on Thursday, November 6, 2025. The Board will consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Q2 FY26). Additionally, the Board will consider adopting a new Employee Stock Option Scheme called ESOS 2025, subject to shareholder approval. The filing is made under Regulation 29 of SEBI Listing Regulations. No financial figures have been disclosed in this intimation; details will be known only after the meeting.
This is a routine pre-results announcement and does not move the stock on its own. Investors should watch for the Q2 FY26 results on November 6 for actual revenue, profit, and margin numbers. The proposed ESOS 2025 could lead to future equity dilution if approved by shareholders, which may be a mild overhang on the stock.